Statistics

Total Visits

Views
Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model 165

Total Visits per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model 18 11 22 10 19 15 9

File Downloads

Views
hdl_139651.pdf 87
AAC00424-23R1-Merged_PDF.pdf 12

Top Country Views

Views
United States 46
Australia 26
Ireland 9
China 6
Belgium 5
Argentina 3
India 3
Hong Kong SAR China 2
Lithuania 2
Sweden 2

Top City Views

Views
Adelaide CBD 19
New York 10
Ashburn 6
Boardman 6
Brussels 5
Clonee 4
Dublin 3
Amritsar 2
Central 2
Haidian 2